Literature DB >> 11804206

Cerebrotendinous xanthomatosis: heterogeneity of clinical phenotype with evidence of previously undescribed ophthalmological findings.

M T Dotti1, A Rufa, A Federico.   

Abstract

Cerebrontendinous xanthomatosis (CTX) is a rare autosomal recessive neurometabolic disease involving lipid metabolism. The classical phenotype is characterized by neurological dysfunction, tendon xanthomas and juvenile cataracts. Other ophthalmological findings have occasionally been reported. To gain more insight into the type and frequency of ophthalmological alterations in this multisystem metabolic disorder, we examined 13 CTX patients. Besides cataracts, found in all cases, the second most frequent ocular abnormality was paleness of the optic disk, which was found in 6 patients and was probably previously underestimated. Signs of premature retinal senescence were also observed. We discuss the possible relation between these ocular manifestations and the metabolic defect.

Entities:  

Mesh:

Year:  2001        PMID: 11804206     DOI: 10.1023/a:1012981019336

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  29 in total

1.  Cerebrotendinous xanthomatosis with predominant parkinsonian syndrome: further confirmation of the clinical heterogeneity.

Authors:  M T Dotti; A Federico; R Garuti; S Calandra
Journal:  Mov Disord       Date:  2000-09       Impact factor: 10.338

Review 2.  Cholesterol and cataracts.

Authors:  R J Cenedella
Journal:  Surv Ophthalmol       Date:  1996 Jan-Feb       Impact factor: 6.048

3.  Juvenile cataract associated with chronic diarrhea in pediatric cerebrotendinous xanthomatosis.

Authors:  J R Cruysberg; R A Wevers; J J Tolboom
Journal:  Am J Ophthalmol       Date:  1991-11-15       Impact factor: 5.258

4.  Mutations in the bile acid biosynthetic enzyme sterol 27-hydroxylase underlie cerebrotendinous xanthomatosis.

Authors:  J J Cali; C L Hsieh; U Francke; D W Russell
Journal:  J Biol Chem       Date:  1991-04-25       Impact factor: 5.157

5.  Four novel mutations of sterol 27-hydroxylase gene in Italian patients with cerebrotendinous xanthomatosis.

Authors:  R Garuti; M A Croce; R Tiozzo; M T Dotti; A Federico; S Bertolini; S Calandra
Journal:  J Lipid Res       Date:  1997-11       Impact factor: 5.922

6.  Cerebrotendinous xanthomatosis: pathophysiological study on bone metabolism.

Authors:  A Federico; M T Dotti; F Loré; R Nuti
Journal:  J Neurol Sci       Date:  1993-03       Impact factor: 3.181

7.  A case of cerebrotendinous xanthomatosis. II: The sterol content of a cataractous lens.

Authors:  P McKenna; S J Morgan; R C Bosanquet; M F Laker
Journal:  Br J Ophthalmol       Date:  1990-10       Impact factor: 4.638

8.  Long-term treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid.

Authors:  V M Berginer; G Salen; S Shefer
Journal:  N Engl J Med       Date:  1984-12-27       Impact factor: 91.245

Review 9.  Biochemical abnormalities in cerebrotendinous xanthomatosis.

Authors:  G Salen; S Shefer; V Berginer
Journal:  Dev Neurosci       Date:  1991       Impact factor: 2.984

10.  The neuropathology of cerebrotendinous xanthomatosis revisited: a case report and review of the literature.

Authors:  D Soffer; D Benharroch; V Berginer
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

View more
  19 in total

Review 1.  Cholesterol oxidation in the retina: implications of 7KCh formation in chronic inflammation and age-related macular degeneration.

Authors:  Ignacio R Rodríguez; Ignacio M Larrayoz
Journal:  J Lipid Res       Date:  2010-06-21       Impact factor: 5.922

2.  The Onion Sign in Neovascular Age-Related Macular Degeneration Represents Cholesterol Crystals.

Authors:  Claudine E Pang; Jeffrey D Messinger; Emma C Zanzottera; K Bailey Freund; Christine A Curcio
Journal:  Ophthalmology       Date:  2015-08-19       Impact factor: 12.079

3.  Isolevuglandins and mitochondrial enzymes in the retina: mass spectrometry detection of post-translational modification of sterol-metabolizing CYP27A1.

Authors:  Casey Charvet; Wei-Li Liao; Gun-Young Heo; James Laird; Robert G Salomon; Illarion V Turko; Irina A Pikuleva
Journal:  J Biol Chem       Date:  2011-04-15       Impact factor: 5.157

4.  Abnormal vascularization in mouse retina with dysregulated retinal cholesterol homeostasis.

Authors:  Saida Omarova; Casey D Charvet; Rachel E Reem; Natalia Mast; Wenchao Zheng; Suber Huang; Neal S Peachey; Irina A Pikuleva
Journal:  J Clin Invest       Date:  2012-07-23       Impact factor: 14.808

5.  Cholestenoic Acid is an important elimination product of cholesterol in the retina: comparison of retinal cholesterol metabolism with that in the brain.

Authors:  Natalia Mast; Rachel Reem; Ilya Bederman; Suber Huang; Pier Luigi DiPatre; Ingemar Bjorkhem; Irina A Pikuleva
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-02-01       Impact factor: 4.799

6.  The role of dentate nuclei in human oculomotor control: insights from cerebrotendinous xanthomatosis.

Authors:  Francesca Rosini; Elena Pretegiani; Andrea Mignarri; Lance M Optican; Valeria Serchi; Nicola De Stefano; Marco Battaglini; Lucia Monti; Maria T Dotti; Antonio Federico; Alessandra Rufa
Journal:  J Physiol       Date:  2017-03-14       Impact factor: 5.182

7.  Features of the retinal environment which affect the activities and product profile of cholesterol-metabolizing cytochromes P450 CYP27A1 and CYP11A1.

Authors:  Gun-Young Heo; Wei-Li Liao; Illarion V Turko; Irina A Pikuleva
Journal:  Arch Biochem Biophys       Date:  2011-12-29       Impact factor: 4.013

8.  Posttranslational modification by an isolevuglandin diminishes activity of the mitochondrial cytochrome P450 27A1.

Authors:  Casey D Charvet; James Laird; Yunfeng Xu; Robert G Salomon; Irina A Pikuleva
Journal:  J Lipid Res       Date:  2013-03-11       Impact factor: 5.922

Review 9.  Epidemiology, diagnosis, and treatment of cerebrotendinous xanthomatosis (CTX).

Authors:  Gerald Salen; Robert D Steiner
Journal:  J Inherit Metab Dis       Date:  2017-10-04       Impact factor: 4.982

Review 10.  Cholesterol in the retina: the best is yet to come.

Authors:  Irina A Pikuleva; Christine A Curcio
Journal:  Prog Retin Eye Res       Date:  2014-04-04       Impact factor: 21.198

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.